Ricky Goldwasser
Stock Analyst at Morgan Stanley
(4.24)
# 422
Out of 4,967 analysts
225
Total ratings
64.81%
Success rate
9.76%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $342 → $325 | $312.55 | +3.98% | 18 | Aug 20, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $33 → $28 | $29.60 | -5.41% | 13 | Aug 4, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $283 → $306 | $277.20 | +10.39% | 17 | Jul 25, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $71 → $60 | $67.03 | -10.49% | 10 | Apr 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $161.55 | +13.90% | 22 | Feb 5, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $5.57 | +79.53% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $4.32 | +27.31% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $16.13 | -53.50% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $16.65 | -27.93% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $181.88 | -20.28% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $184.50 | +97.83% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $692.63 | -39.36% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $6.81 | +1,662.11% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $310.95 | +99.39% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $323.36 | +54.63% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $74.36 | +66.76% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $305.83 | +3.98% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $149.65 | -53.22% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $186.00 | +4.84% | 6 | Oct 21, 2020 |
UnitedHealth Group
Aug 20, 2025
Maintains: Overweight
Price Target: $342 → $325
Current: $312.55
Upside: +3.98%
Centene
Aug 4, 2025
Maintains: Equal-Weight
Price Target: $33 → $28
Current: $29.60
Upside: -5.41%
Labcorp Holdings
Jul 25, 2025
Maintains: Overweight
Price Target: $283 → $306
Current: $277.20
Upside: +10.39%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71 → $60
Current: $67.03
Upside: -10.49%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $161.55
Upside: +13.90%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.57
Upside: +79.53%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $4.32
Upside: +27.31%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $16.13
Upside: -53.50%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $16.65
Upside: -27.93%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $181.88
Upside: -20.28%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $184.50
Upside: +97.83%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $692.63
Upside: -39.36%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $6.81
Upside: +1,662.11%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $310.95
Upside: +99.39%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $323.36
Upside: +54.63%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $74.36
Upside: +66.76%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $305.83
Upside: +3.98%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $149.65
Upside: -53.22%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $186.00
Upside: +4.84%